CLL
Item
patients with histologically or cytologically confirmed cll
boolean
C0023434 (UMLS CUI [1])
Hemoglobin and platelet count
Item
patients with hemoglobin concentration and/or platelet count below the institution's lower limit of normal
boolean
C0518015 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
No chemotherapy or radiotherapy
Item
patients who have not received cancer chemotherapy or radiotherapy
boolean
C0392920 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Infections
Item
patients with apparent infections (including viral infections)
boolean
C0009450 (UMLS CUI [1])
Complications
Item
patients with serious complications (heart, liver, or kidney disease, etc.)
boolean
C0009566 (UMLS CUI [1])
Bleeding tendency
Item
patients with a serious bleeding tendency (e.g., dic)
boolean
C0005779 (UMLS CUI [1])
CNS symptoms
Item
patients with serious cns symptoms
boolean
C0422879 (UMLS CUI [1])
Fever (excluding tumor fever)
Item
patients with fever >= 38°c (excluding tumor fever)
boolean
C0015967 (UMLS CUI [1])
C0332196 (UMLS CUI [2,1])
C0948348 (UMLS CUI [2,2])
Interstitial pneumonia or pulmonary fibrosis
Item
patients with interstitial pneumonia or pulmonary fibrosis
boolean
C0206061 (UMLS CUI [1])
C0034069 (UMLS CUI [2])
Multiple cancers
Item
patients with active multiple cancers
boolean
C0346429 (UMLS CUI [1])
Experimental drug
Item
patients receiving other investigational products within 6 months before registration in this study
boolean
C0304229 (UMLS CUI [1])
Allergy to trial product
Item
patients with prior allergies to medications that are similar to the investigational product (purine nucleoside derivatives)
boolean
C0020517 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])
Gynaecological status
Item
women who are pregnant, of childbearing potential, or lactating
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2])
C0006147 (UMLS CUI [3])